Status:

COMPLETED

Iron Therapy for Autosomal Dominant Hypophosphatemic Rickets: A Pilot Project.

Lead Sponsor:

Indiana University

Conditions:

Autosomal Dominant Hypophosphatemic Rickets

Eligibility:

All Genders

25+ years

Phase:

NA

Brief Summary

The purpose of the study is to gain a better understanding of the effect of iron on fibroblast growth factor 23 (FGF23) in the inherited disorder, autosomal dominant hypophosphatemic rickets (ADHR). A...

Detailed Description

Iron will be provided in an open label treatment to all enrolled subjects. Iron levels will be monitored in blood and doses adjusted with the target of getting the iron levels to or a little above 100...

Eligibility Criteria

Inclusion

  • FGF Mutation in either Arginine 176 or arginine 179
  • able and willing to provide consent or have a parent that is able/willing to consent, if a minor
  • either serum iron \<50mcg/dl (regardless of phosphate or intact FGF23 concentration); or iron between 500 and 100mcg/dl with serum phosphorus value below 3.0mg/dl for adults or less than or equal to 0.5 mg/dl the lower limit of normal for age in children and intact FGF23 about 30pg/ml
  • age \>2 years
  • May be receiving treatment with phosphate and calcitriol, but must be willing to undergo dose adjustments by the investigators if iron resolves the phosphate wasting defect.

Exclusion

  • malignancy within the last 5 years, except treated squamous or basal cell skin carcinoma
  • terminal illness/hospice.
  • severe end-organ disease, e.g. cardiovascular, pulmonary, etc, which may limit ability to complete study.
  • estimated GFR \<45ml/min/1.73m2, calculated using MDRD formula for adults or modified Schwartz equation for children
  • pregnancy or plan on becoming pregnant

Key Trial Info

Start Date :

August 1 2014

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 12 2019

Estimated Enrollment :

8 Patients enrolled

Trial Details

Trial ID

NCT02233322

Start Date

August 1 2014

End Date

November 12 2019

Last Update

November 14 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Indiana University School of Medicine

Indianapolis, Indiana, United States, 46202

Iron Therapy for Autosomal Dominant Hypophosphatemic Rickets: A Pilot Project. | DecenTrialz